A PHASE1/2 CLINICAL TRIAL OF VELIPARIB (ABT-888) AND RADIATION FOLLOWED BY MAINTENANCE THERAPY WITH VELIPARIB AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): A PEDIATRIC BRAIN TUMOR CONSORTIUM INTERIM REPORT OF PHASE II STUDY

被引：0

作者：

Baxter, Patricia ^{[1
]}

Su, Jack ^{[1
]}

Li, Xiao-nan ^{[1
]}

Thomas, Arzu Onar ^{[2
]}

Billups, Catherine ^{[2
]}

Thompson, Patrick ^{[3
]}

Poussaint, Tina ^{[4
]}

McKeegan, Evelyn ^{[5
]}

Wan, Xia ^{[5
]}

Ansell, Peter ^{[5
]}

Giranda, Vincent ^{[5
]}

Paulino, Arnold ^{[6
]}

Kilburn, Lindsay ^{[7
]}

Qaddoumi, Ibrahim ^{[8
]}

Broniscer, Alberto ^{[8
]}

Blaney, Susan ^{[1
]}

Boyett, James ^{[2
]}

Fouladi, Maryam ^{[1
]}

机构：

[1] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA

[2] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA

[3] Univ N Carolina, North Carolina Childrens Hosp, Chapel Hill, NC USA

[4] Childrens Hosp Boston, Boston, MA USA

[5] AbbVie, Abbvie Pk, IL USA

[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[7] Childrens Natl Med Ctr, Washington, DC 20010 USA

[8] St Jude Res Hosp, Memphis, TN USA

来源：

NEURO-ONCOLOGY | 2016年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EPT-15

引用

页码：27 / 27

页数：1

共 36 条

[31] INTERIM CLINICAL, PHARMACOKINETIC, AND TECHNICAL REPORT OF A PHASE 2 STUDY OF SONODYNAMIC THERAPY (SDT) USING SONALA-001 TOGETHER WITH MR-GUIDED LOW-INTENSITY FOCUSED ULTRASOUND (MRGFUS) IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
Syed, Hasan R.
Packer, Roger J.
Fonseca, Adriana
Keating, Robert F.
Mueller, Sabine
Narsinh, Kazim
Ho, Winson
Niazi, Toba
Fenn, Peter
Clanton, Ryan
Henry, Lenora
Potter, Wyatt
Andresen, Corina
Marcus, Stuart
Benaim, Ely
Kilburn, Lindsay
NEURO-ONCOLOGY, 2024, 26
[32] A PHASE 1/2 STUDY ASSESSING SAFETY AND PHARMACOKINETICS OF CEMIPLIMAB IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID OR CENTRAL-NERVOUS-SYSTEM TUMORS AND SAFETY AND EFFICACY OF CEMIPLIMAB IN COMBINATION WITH RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA, NEWLY DIAGNOSED HIGH-GRADE GLIOMA, OR RECURRENT HIGH-GRADE GLIOMA
Kline, Cassie
Schoenfeld, Jonathan D.
Gajjar, Amar
Tinkle, Christopher
Margol, Ashley
Davidson, Tom
Bendel, Anne
Skrypek, Mary
Kilburn, Lindsay
Packer, Roger
Reddy, Alyssa T.
Abdelbaki, Mohamed S.
Rubin, Josh
Sayour, Elias
Mitchell, Duane
Chi, Susan
Waanders, Angela J.
Elster, Jennifer
Baxter, Patricia
Crotty, Erin
Cohen, Kenneth
Moertel, Christopher
Franson, Andrea T.
Whipple, Nicholas S.
Bansal, Shikha
Jankovic, Vladimir
Kaul, Manika
Paccaly, Anne
Zhong, Bob
Schmidt, Tamara
Lowy, Israel
Seebach, Frank
Liu, Kevin
Gunasti, Lauren
Morinigo, Denise
Singh, Shefali
Shai, Anny
Phillips, Joanna
Filbin, Mariella
Nazarian, Javad
Catalano, Paul
Prados, Michael
Haas-Kogan, Daphne
Magnan, Heather
Mueller, Sabine
NEURO-ONCOLOGY, 2024, 26
[33] MOLECULAR AND BIOLOGY CORRELATIVE RESULTS FROM THE PHASE 1B TRIAL OF UNESBULIN (PTC596) WITH RADIOTHERAPY IN CHILDREN NEWLY-DIAGNOSED WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT)
Lazow, Margot
Baxter, Patricia
Kumar, Shiva Senthil
Mohamad, Maya
Mackay, Alan
Stanek, Joseph
Rodriguez, Diana
Palmer, Joshua
Leach, James
Mikael, Leonie
Thomas, Diana
Fuller, Christine
Boue, Daniel
Pierson, Christopher
Breneman, John
Li, Xiao-Nan
Salloum, Ralph
Ashley, David
de Blank, Peter
Hwang, Eugene
Leary, Sarah
Plant, Ashley
Fisher, Michael
Chi, Susan
Murala, Mythili
Weetall, Marla
Rance, Mark
Baird, John
D'Silva, Dhiren
O'Keefe, Kylie
Leonard, Jeffrey
Stewart, Clinton
Jones, Chris
Mardis, Elaine
Fouladi, Maryam
Drissi, Rachid
NEURO-ONCOLOGY, 2024, 26
[34] CeCil: A randomized, noncomparative phase II clinical trial of the effect of radiation therapy (RT) plus temozolomide (TMZ) combined with cilengitide or cetuximab on the 1-year overall survival of patients with newly diagnosed MGMT-promoter unmethylated glioblastoma.
Verschaeve, V.
D'Hondt, L. A.
Verbeke, L. M. J.
Van Fraeyenhove, F.
Du Four, S.
Duerinck, J.
Neyns, B.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[35] PHASE I STUDY OF ADOPTIVE CELLULAR THERAPY (X-ALT) PLUS TOTAL TUMOR RNA-DENDRITIC CELL VACCINE (TTRNA-DC) plus HEMATOPOIETIC STEM CELLS (HSC) DURING RECOVERY FROM IRRADIATION(RT) WITH (GROUP A) OR WITHOUT (GROUP B) DOSE-INTENSIFIED TEMOZOLOMIDE (DI-TMZ) IN PATIENT (PTS) WITH NEWLY DIAGNOSED DIFFUSE BRAIN STEM GLIOMAS (DIPG) (BRAVO TRIAL)
Gururangan, Sridharan
Sayour, Elias
Flores, Catherine
Hodik, Marcia
Mitchell, Duane
NEURO-ONCOLOGY, 2017, 19 : 9 - 9
[36] REPORT ON PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC)-029B, A PROSPECTIVE PHASE 2 CLINICAL TRIAL OF SELUMETINIB IN TREATING YOUNG PATIENTS WITH RECURRENT/PROGRESSIVE LOW-GRADE GLIOMA: NEW RESULTS ON STRATA 2, 5, AND 6 WITH UPDATED LONG-TERM SURVIVAL OUTCOMES ON STRATA 1, 3, AND 4
Fangusaro, Jason
Onar-Thomas, Arzu
Poussaint, Tina Young
Lensing, Shelly
Ligon, Azra H.
Lindeman, Neal
Banerjee, Anuradha
Kilburn, Lindsay
Lenzen, Alicia
Pillay-Smiley, Natasha
Pollack, Ian F.
Robison, Nathan
Partap, Sonia
Qaddoumi, Ibrahim
Landi, Daniel
Jones, David T. W.
Stewart, Clinton F.
Fouladi, Maryam
Dunkel, Ira J.
NEURO-ONCOLOGY, 2024, 26

← 1 2 3 4 →